Advertisement
Screener

NeuroSense Therapeutics Ltd. (NRSN) Form 6-K: Report of foreign private issuer, 2022

NeuroSense Therapeutics Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2022-12-15: Form 6-K; Period of report 2022-12-15; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea170292-6k_neurosense.htm.
  • 2022-12-01: Form 6-K; Period of report 2022-12-01; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea169518-6k_neurosense.htm.
  • 2022-11-29: Form 6-K; Period of report 2022-11-29; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea168944-6k_neurosense.htm.
  • 2022-11-16: Form 6-K; Period of report 2022-11-16; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea168817-6k_neurosense.htm.
FiledFormPeriod of reportDescriptionDocument
2022-12-156-K2022-12-15REPORT OF FOREIGN PRIVATE ISSUERea170292-6k_neurosense.htm
2022-12-016-K2022-12-01REPORT OF FOREIGN PRIVATE ISSUERea169518-6k_neurosense.htm
2022-11-296-K2022-11-29REPORT OF FOREIGN PRIVATE ISSUERea168944-6k_neurosense.htm
2022-11-166-K2022-11-16REPORT OF FOREIGN PRIVATE ISSUERea168817-6k_neurosense.htm
2022-11-156-K2022-11-15REPORT OF FOREIGN PRIVATE ISSUERea168706-6k_neurosense.htm
2022-11-036-K2022-11-03REPORT OF FOREIGN PRIVATE ISSUERea167996-6k_neurosense.htm
2022-10-126-K2022-10-12REPORT OF FOREIGN PRIVATE ISSUERea167032-6k_neurosense.htm
2022-09-286-K2022-09-28REPORT OF FOREIGN PRIVATE ISSUERea166444-6k_neurosense.htm
2022-09-206-K2022-09-20REPORT OF FOREIGN PRIVATE ISSUERea166046-6k_neurosense.htm
2022-09-166-K2022-09-16REPORT OF FOREIGN PRIVATE ISSUERea165875-6k_neurosense.htm
2022-08-316-K2022-08-31REPORT OF FOREIGN PRIVATE ISSUERea165184-6k_neurosense.htm
2022-08-166-K2022-08-16REPORT OF FOREIGN PRIVATE ISSUERea164506-6k_neurosensether.htm
2022-08-096-K2022-08-09REPORT OF FOREIGN PRIVATE ISSUERea164039-6k_neurosense.htm
2022-08-026-K2022-08-02REPORT OF FOREIGN PRIVATE ISSUERea163714-6k_neurosense.htm
2022-08-016-K2022-08-01REPORT OF FOREIGN PRIVATE ISSUERea163638-6k_neurosense.htm
2022-07-286-K2022-07-28REPORT OF FOREIGN PRIVATE ISSUERea163477-6k_neurosense.htm
2022-07-186-K2022-07-18REPORT OF FOREIGN PRIVATE ISSUERea162981-6k_neurosense.htm
2022-07-136-K2022-07-13REPORT OF FOREIGN PRIVATE ISSUERea162781-6k_neurosense.htm
2022-07-056-K2022-07-05REPORT OF FOREIGN PRIVATE ISSUERea162416-6k_neurosense.htm
2022-07-016-K2022-07-01Report of foreign private issuerea162311-6k_neurosense.htm
2022-06-306-K2022-06-30REPORT OF FOREIGN PRIVATE ISSUERea162301-6k_neurosense.htm
2022-06-296-K2022-06-29REPORT OF FOREIGN PRIVATE ISSUERea162237-6k_neurosense.htm
2022-06-276-K2022-06-27REPORT OF FOREIGN PRIVATE ISSUERea162090-6k_neurosense.htm
2022-06-226-K2022-06-22FORM 6-Kea161926-6k_neurosense.htm
2022-06-076-K2022-06-07REPORT OF FOREIGN PRIVATE ISSUERea161264-6k_neurosense.htm
2022-06-016-K2022-06-01REPORT OF FOREIGN PRIVATE ISSUERea160935-6k_neurosense.htm
2022-05-316-K2022-05-31REPORT OF FOREIGN PRIVATE ISSUERea160817-6k_neurosense.htm
2022-05-196-K2022-05-19REPORT OF FOREIGN PRIVATE ISSUERea160336-6k_neurosense.htm
2022-05-116-K2022-05-11REPORT OF FOREIGN PRIVATE ISSUERea159770-6k_neurosense.htm
2022-05-026-K2022-05-02REPORT OF FOREIGN PRIVATE ISSUERea159186-6k_neurosense.htm
2022-04-116-K2022-04-11REPORT OF FOREIGN PRIVATE ISSUERea158299-6k_neurosense.htm
2022-03-306-K2022-03-30CURRENT REPORTea157597-6k_neurosense.htm
2022-03-256-K2022-03-25REPORT OF FOREIGN PRIVATE ISSUERea157413-6k_neurosense.htm
2022-03-216-K2022-03-21REPORT OF FOREIGN PRIVATE ISSUERea157170-6k_neurosense.htm
2022-03-156-K2022-03-15REPORT OF FOREIGN PRIVATE ISSUERea156899-6k_neurosense.htm
2022-02-156-K2022-02-15REPORT OF FOREIGN PRIVATE ISSUERea155743-6k_neurosense.htm
2022-01-316-K2022-01-31REPORT OF FOREIGN PRIVATE ISSUERea154714-6k_neurosense.htm
2022-01-276-K2022-01-27Report of foreign private issuerea154563-6k_neurosense.htm
2022-01-266-K2022-01-26REPORT OF FOREIGN PRIVATE ISSUERea154521-6k_neurosense.htm
2022-01-046-K2022-01-04FORM 6-Kea153462-6k_neurosense.htm